Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, and Lactobacillus delbrueckii LDD01) in patients undergoing bowel preparation

Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, and Lactobacillus delbrueckii LDD01) in patients undergoing bowel preparation

Authors

  • Luigi Bonavina Surgery Unit, San Donato Hospital, Milan, Italy
  • Andrea Ariani Gastroenterology Unit, Policlinico Paolo Giaccone, Palermo, Italy
  • Leonardo Ficano Gastroenterology Unit, Universioty of Palermo, Palermo, Italy
  • Domenico Iannuzziello Digestive Endoscopy, Mater Dei Hospital, Bari, Italy
  • Luigi Pasquale Gastroenterology Unit, Avellino Hospital, Avellino, Italy
  • Salvo Emanuele Aragona Center of Regenerative Medicine, Humanitas Mater Domini, Castellanza (VA), Italy
  • Lorenzo Drago Microbiology Department, University of Milan, Milan, Italy
  • Giorgio Ciprandi Allergy Clinic, Casa di Cura Villa Montallegro, Genoa, Italy
  • Italian Study Group on digestive disorders

Keywords:

bowel preparation, gut microbiota, colonoscopy, probiotics, survey

Abstract

Bowel preparation (BP) for colonoscopy induces significantly changes in gut microbiota and elicit intestinal symptoms. Impaired microbiota causes an intestinal dysbiosis. Consequently, probiotics may counterbalance the disturbed microbiota after BP. The current survey evaluated the efficacy and safety of Abincol®, an oral nutraceutical containing a probiotic mixture with Lactobacillus plantarum LP01 (1 billion of living cells), Lactobacillus lactis subspecies cremoris LLC02 (800 millions of living cells), and Lactobacillus delbrueckii LDD01 (200 millions of living cells), in 2,979 outpatients (1,579 males and 1,400 females, mean age 56 years) undergoing BP. Patients took 1 stick/daily for 4 weeks after colonoscopy. Abincol® significantly diminished the presence and the severity of intestinal symptoms and improved stool form. In conclusion, the current survey suggests that Abincol® may be considered an effective and safe therapeutic option in the management of patients undergoing BP.

Downloads

Published

10-07-2019

How to Cite

1.
Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, and Lactobacillus delbrueckii LDD01) in patients undergoing bowel preparation. Acta Biomed [Internet]. 2019 Jul. 10 [cited 2024 May 28];90(7-S):13-7. Available from: https://mattioli1885journals.com/index.php/actabiomedica/article/view/8650

Most read articles by the same author(s)

1 2 3 4 5 6 7 > >>